Black Friday offer50% off your first month

CJC-1295 & ipamorelin benefits & dosage

Two peptides, one pre-filled pen

Inside Peppi's CJC + Ipamorelin pen: what the research shows, and how a clinician sets your dose.

  • Black Friday: 50% Off Your First Month
  • 100% refund if prescription not approved
  • Third-Party Lab Tested
  • Free 2-Day Shipping
A round disc made of two halves, one white and one blue, standing on a plinth

Peppi puts CJC‑1295 (no DAC) and ipamorelin in one ready‑to‑use, pre‑filled pen that ships only after a clinician licensed in your state reviews your intake. Nothing has to be reconstituted or measured, and every batch is third‑party lab tested before it reaches your door.

This guide covers what each peptide does, what human research tested, why the pen uses the no‑DAC form, and how a clinician handles dosing and timing.

The short answer

CJC-1295 + ipamorelin pairs two growth hormone peptides in one pen: CJC-1295 (no DAC) 10 mg and ipamorelin 10 mg, 20 mg in total. Peppi lists three studied-for tags on the pen, Muscle Growth Support, Fat Loss Support and Sleep & Recovery. No peer-reviewed human study has tested the no-DAC form or the pairing, so a licensed clinician weighs your goals and sets your dose.

  • CJC‑1295 (no DAC) 10 mg & ipamorelin 10 mg
  • Third‑party tested, batch by batch
  • A licensed clinician sets your dose
  • Pre‑filled pen, nothing to mix or measure

Chapter 01 of 07

How CJC-1295 + ipamorelin works

Two pituitary routes

CJC‑1295 + ipamorelin is a pairing of two peptides that prompt your own pituitary to release growth hormone, each through a different receptor. Peppi's CJC-1295 + Ipamorelin pen holds CJC‑1295 (no DAC) 10 mg and ipamorelin 10 mg, 20 mg in total, as a one‑month supply.

CJC‑1295 is a lab‑made version of GHRH, the brain signal that tells the pituitary to release growth hormone. Peppi's pen uses the no‑DAC form of it.

Ipamorelin takes the other road. A 1998 paper in the European Journal of Endocrinology introduced it as a pentapeptide that released growth hormone from rat pituitary cells and in conscious swine. In people, a 1999 phase I study recorded one growth hormone episode that peaked around 40 minutes after an intravenous infusion.

The ghrelin receptor also sits in the gut. In the ghrelin mimetic gut study, rats had abdominal surgery that slowed stomach emptying, and intravenous ipamorelin sped it up again through a ghrelin receptor mechanism. That finding is in rats.

The pair is searched far more often than it is studied: a PubMed search for cjc 1295 ipamorelin in November 2026 returned 11 records, all reviews or doping‑control method papers, with no trial of the combination in people.

Peppi's CJC + Ipamorelin pen is a compounded prescription peptide and is not FDA‑approved. A clinician licensed in your state reviews your intake, and a licensed U.S. compounding pharmacy fills it.

Key takeawayTwo peptides, two pituitary routes, one pre‑filled prescription pen.

Chapter 02 of 07

CJC-1295 ipamorelin benefits

Studied for three goals

The cjc 1295 ipamorelin benefits Peppi names are three studied‑for tags on the pen: Muscle Growth Support, Fat Loss Support and Sleep & Recovery. Peppi's own line sits right under them: "Studied for, not promised. Your clinician helps you decide what's right for you."

In a 2006 study in the Journal of Clinical Endocrinology & Metabolism, two randomized, placebo‑controlled, double‑blind ascending‑dose trials gave CJC‑1295 with DAC to healthy adults aged 21 to 61. A single injection raised mean plasma growth hormone 2 to 10 fold for 6 days or more.

Any list of cjc 1295 benefits needs the form attached to it. Neither 2006 trial used the no‑DAC peptide in Peppi's pen, and a 2026 narrative review in Frontiers in Endocrinology states it plainly: "CJC‑1295 without DAC remains essentially uncharacterised in the peer‑reviewed human literature."

Ipamorelin's one controlled trial in patients measured something else. Beck and colleagues enrolled 117 adults after bowel resection in a 2014 phase 2 study. Median time to a first tolerated meal was 25.3 hours on ipamorelin and 32.6 on placebo, not a significant difference.

A PubMed search in November 2026 for either peptide alongside body composition, lean mass or muscle, limited to clinical trials, returned no records. Human data covers the DAC form and ipamorelin alone, not the pair, so a clinician reviews your goals and health history first.

DetailStudied inWhat was reported
CJC-1295 with DACHealthy adults, two 2006 trialsGrowth hormone and IGF‑1 both rose
CJC-1295 no DACNo peer‑reviewed human studyEffects inferred from related peptides
IpamorelinHealthy men, then 114 of 117 patients analyzedOne growth hormone burst, no meal benefit
The two togetherNo trial in peopleA clinician weighs your goals

Key takeawayPeppi names the studied‑for goals and the form in the pen, and your clinician helps you decide what's right for you.

Chapter 03 of 07

Why Peppi uses CJC-1295 no DAC

Short acting by design

Peppi's pen holds the short‑acting version. In the words of its FAQ, cjc 1295 no dac is "CJC‑1295 without the drug affinity complex, the add‑on that binds the blood protein albumin and stretches its effect over days." It is also called modified GRF (1‑29).

Peppi's spec panel sets the two side by side. The no‑DAC form is "The 29 amino acids alone" and short‑acting, while the DAC version "Adds Lys30, which binds albumin: half‑life 5.8‑8.1 days, GH up for days."

That split matters for reading research. The DAC form is the one with randomized human trials, and Peppi's FAQ says a 2026 review found no peer‑reviewed human studies of the no‑DAC form. The two forms are not interchangeable, so figures from DAC studies do not transfer to the no‑DAC peptide in Peppi's pen.

Peppi lists each peptide with its milligrams on the product page.

Peppi does not offer CJC‑1295 alone, ipamorelin alone or the DAC form.

Good to knowPeppi names the form on the product page, so you know which version you have and which research applies.

Key takeawayShort acting by design: 29 amino acids, no albumin‑binding add‑on.

Chapter 04 of 07

CJC-1295 ipamorelin dosage

Set by your clinician

There is no established cjc 1295 ipamorelin dosage. No FDA‑approved drug product contains either peptide, so no prescribing information sets an amount, and Peppi's own page says it directly: "There is no established dose for healthy adults."

What is fixed is the pen: CJC‑1295 (no DAC) 10 mg and ipamorelin 10 mg, pre‑mixed as a one‑month supply.

Your amount is a clinical decision. Peppi's FAQ page says "Your dose is personalized based on your health information, goals, and treatment plan." A clinician licensed in your state sets it from your intake, and the twist‑to‑dose selector delivers it. Peppi's own information for this pen says drugs that raise growth hormone can raise blood sugar, and that treatment carries risks and may not be appropriate for everyone, which is part of what the clinician weighs.

Look for a cjc-1295 ipamorelin dosage per day and most of what comes back is forum practice. The 2026 Frontiers in Endocrinology review says the claims behind those online patterns rest on extrapolation and grey‑literature user narratives.

A dosing chart only matters if you measure doses yourself, and with this pen you do not. Peppi describes its pens as "pre‑filled and ready to use", with no powders to mix and nothing to draw from a vial.

Independent labs test every batch for potency, sterility, pH and endotoxicity before it ships, and your lot number is printed on the pen label. Look your lot up in Peppi's batch test results.

Good to knowFound a dosing chart online? Only your clinician changes your dose, so bring the question to your care team.

Key takeawayNo label, no chart: your clinician sets the dose and the pen dials it.

Chapter 05 of 07

Best time to take CJC-1295 ipamorelin

What studies timed

Ask what the best time to take cjc 1295 ipamorelin is and there is no label to answer with, because neither peptide has an approved product. Your schedule comes from your clinician.

Published studies do carry timing detail. In that 1999 phase I work, growth hormone rose in one episode peaking about 40 minutes after the infusion, and ipamorelin itself had a terminal half‑life near 2 hours.

Sleep comes up because of the hormone your body already makes. A 2000 JAMA analysis pooled data from 149 healthy men aged 16 to 83, with 24‑hour growth hormone profiles and sleep recordings. Independently of age, growth hormone secretion was significantly associated with slow wave sleep. No peptide was given in it.

Peppi lists Sleep & Recovery among the pen's studied‑for tags, so the pathway and the question are connected. The measurement is not. A PubMed search in November 2026 pairing ipamorelin with sleep terms returned 2 records, both reviews, and no trial.

Key takeawayNo label sets a time, so timing is a clinician question, not a forum one.

Chapter 06 of 07

Ipamorelin dosage on its own

Only inside the pen

Peppi does not offer ipamorelin as a single‑peptide pen, so there is no Peppi ipamorelin dosage to quote. The peptide comes only inside the CJC + Ipamorelin pen, which holds 10 mg of it beside 10 mg of CJC‑1295 (no DAC).

The human studies that exist dosed it in a hospital: 15‑minute intravenous infusions in healthy men in 1999, and infusions twice daily for up to seven days after bowel resection in 2014. Neither was a routine anyone followed at home, and neither measured muscle or fat.

Those studies did describe selectivity. In the 1998 swine work, ipamorelin did not release ACTH or cortisol at levels significantly different from GHRH stimulation, unlike GHRP‑6 and GHRP‑2. The 2026 review calls it "a relatively selective agonist of the GHSR‑1a receptor".

So a figure from an infusion study is not a dose for you. Your clinician sets what you dial on the pen.

Key takeawayIpamorelin has no approved label, and Peppi offers it only inside one pen.

Chapter 07 of 07

Results to expect from the pair

Months, not days

Peppi frames ipamorelin cjc 1295 results in months rather than days. It calls peptide therapy cumulative and recommends that patients commit 4 to 6 months for results to build.

That is Peppi's guidance rather than a trial result. No published human study has measured this pairing on muscle, fat, recovery or sleep.

Chris H., a verified buyer, described the CJC + Ipamorelin pen this way: "The very first thing I noticed with the CJC‑1295 and Ipamorelin combo was how much better my workouts were. I started leaning out and retaining muscle much easier without changing my diet. I've been a loyal Peppi customer ever since." That is one person's experience, not a typical result, and results vary.

What Peppi publishes is the process, with real timings. The intake takes under 2 minutes, in most cases a licensed clinician reviews your information within 24 hours, and an approved order arrives within 2 to 3 days. Refills come every 28 days.

One rule shapes the choice between performance pens. You can only be prescribed one growth hormone peptide at a time, so Tesamorelin and CJC + Ipamorelin are never prescribed together. Peppi's Tesamorelin pen has randomized, placebo‑controlled trials behind it in adults with HIV, and Peppi's MOTS-c pen takes a different pathway for energy and endurance goals. A licensed clinician determines which one is appropriate for you.

The CJC + Ipamorelin pen is $189 for the first month on a subscription, then $303 a month, or $379 as a one‑time purchase. If your prescription isn't approved, you get a 100% refund.

CJC + Ipamorelin pre-filled peptide pen

Featured pen

CJC + Ipamorelin

CJC-1295 (no DAC) 10 mg and ipamorelin 10 mg in one ready-to-use, pre-filled pen. A clinician licensed in your state reviews your intake before anything ships.

$189 first month$379Add to cart

Not sure which performance pen fits your goals?

Take the Quiz

Key takeawayPeppi measures progress in months, with a care team to check in with.

Questions about CJC-1295 & ipamorelin

Frequently asked questions

How Long Does CJC-1295 & Ipamorelin Take to Work?

Peppi calls peptide therapy cumulative and recommends committing 4 to 6 months for results to build, with a clinician tracking your response. There is no published timeline for the pairing, because the no-DAC form of CJC-1295 has no peer-reviewed human studies. Each pen is a one-month supply refilled every 28 days.

Should You Take CJC-1295 & Ipamorelin Before Bed?

A licensed clinician sets your schedule along with your dose, so timing is a question for your care team. No approved label exists for either peptide, and a November 2026 PubMed search found no trial testing either one for sleep. A 2000 JAMA analysis of 149 healthy men did link the body's own growth hormone to slow wave sleep, with no peptide given.

Can You Take CJC-1295 & Ipamorelin With Tesamorelin?

A licensed clinician weighs your goals and picks one growth hormone peptide to prescribe. You can only be prescribed one growth hormone peptide at a time, so Tesamorelin and CJC + Ipamorelin are never prescribed together. Tesamorelin carries randomized trials in adults with HIV, while CJC-1295 and ipamorelin are studied for muscle, fat loss and sleep support.

These peptides are not FDA-approved and are dispensed only with a prescription.

Peptide guides from Peppi

Keep reading